 Aptorum Group Limited Nasdaq:APM Aptorum Group, a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, including orphan diseases, infectious diseases and metabolic diseases, today announced its participation at Maxim Groups Infectious Disease Virtual Conference on May 5, 2020, 10:00 a.m. ET. Aptorum Groups President and Executive Director Mr. Darren Lui will join a panel, which entitled Non-antibiotic Anti-infectives. This panel is scheduled for 10:30 a.m. ET to 12:00 p.m. ET. To RSVP for the virtual conference, please click through: 